Rezzayo™ (rezafungin) – New drug approval
March 22, 2023 - Cidara Therapeutics and Melinta Therapeutics announced the FDA approval of Rezzayo (rezafungin), in patients 18 years of age or older who have limited or no alternative options for the treatment of candidemia and invasive candidiasis.
Download PDF
